The current price of MLTX is $11.56 — it has decreased by 1.20% since the previous close. Data as of Nov 4, 2026.
MLTX is down 7.07% over the past week, up 1.31% over the past month and up 14.12% over the past year. The price is below its 200-day moving average of $16.41.
Analysts' average 12-month price target for MLTX is $50.00, which implies 332.53% upside from the current price. Individual estimates range from $50.00 to $50.00.
MoonLake Immunotherapeutics has a market capitalization of $983.83M. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, MoonLake Immunotherapeutics posted a loss of $0.84 per share against an estimate of -$0.9086, beating expectations by 7.55%. Upcoming reports are listed in the earnings calendar.
MoonLake Immunotherapeutics has not paid any dividends over the past year.
In the latest trading session MLTX moved between $10.96 and $11.90, a range of 8.17% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of MoonLake Immunotherapeutics shows a sell rating today and a sell rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks MLTX has traded between $9.46 and $23.29. The current price is 50.36% below its 52-week high.
Figures as of Nov 4, 2026. This information is provided for general purposes only and is not investment advice.